drugset / Trial / NCT01053312
PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
NaSingle-groupOpen-labelDiagnostic
Summary
This study will determine the level of association between the quantitative estimates of brain uptake of \[18F\]flutemetamol and the quantitative immunohistochemical estimates of amyloid levels in biopsy samples previously obtained during shunt placement in patients who have normal pressure hydrocephalus (NPH).
Timeline
- Start
- 2009-12
- Primary completion
- 2010-07
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flutemetamol | Diagnostic / imaging agent | 10 ug | Intravenous |
| Subject | Flutemetamol | Diagnostic / imaging agent | 185 mbq | Intravenous |